Showing results (1-10 of 68) with videos related to
Sort By:
Pageof 7
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|September 3, 2019
Feasibility of sentinel lymph node mapping of the ovary: a systematic reviewFederica Dell'Orto, Pim Laven, Martina Delle Marchette, et al.International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|August 5, 2016
Use of PlasmaJet for Peritoneal Carcinomatosis in Ovarian CancerEnrico Panuccio, Karin Leunen, Els Van Nieuwenhuysen, et al.Expert Review of Anticancer Therapy|July 24, 2013
Genetic changes in nonepithelial ovarian cancerEls Van Nieuwenhuysen, Sandrina Lambrechts, Diether Lambrechts, et al.International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|March 22, 2018
Positive DESKTOP and Tian Scores Systems Are Adequate to Predict Optimal (R0) Secondary Debulking Surgery in Ovarian Cancer, But a Negative Score Does Not Preclude Secondary SurgeryTina Laga, Sandrina Lambrechts, Annouschka Laenen, et al.Journal of Ovarian Research|October 14, 2021
Sentinel lymph node identification in early stage ovarian cancer: is it still possible after prior tumor resection?Pim Laven, Roy Kruitwagen, Petra Zusterzeel, et al.Gynecologic Oncology|July 22, 2025
Impact of lymph node dissection and adjuvant chemotherapy on survival of patients with early-stage ovarian cancer: Update of a national cohort studyPim Laven, Hans H B Wenzel, Maaike A van der Aa, et al.Ultraschall in Der Medizin (Stuttgart, Germany : 1980)|August 24, 2017
Simple Rules, Not So Simple: The Use of International Ovarian Tumor Analysis (IOTA) Terminology and Simple Rules in Inexperienced Hands in a Prospective Multicenter Cohort StudyEvelyne Meys, Iris Rutten, Roy Kruitwagen, et al.Cancers|December 17, 2024
Patient-Representative Cell Line Models in a Heterogeneous Disease: Comparison of Signaling Transduction Pathway Activity Between Ovarian Cancer Cell Lines and Ovarian CancerCynthia S E Hendrikse, Pauline M M Theelen, Wim Verhaegh, et al.Oncotargets and Therapy|September 24, 2014
HIF1α is an independent prognostic factor for overall survival in advanced primary epithelial ovarian cancer - a study of the OVCAD ConsortiumElena Ioana Braicu, Hrvoje Luketina, Rolf Richter, et al.BMC Pharmacology & Toxicology|April 17, 2015
Genetic variability in drug transport, metabolism or DNA repair affecting toxicity of chemotherapy in ovarian cancerSandrina Lambrechts, Diether Lambrechts, Evelyn Despierre, et al.Pageof 7